Sep 9, 2025 07:05AM
Sep 9, 2025 07:05AM
Jul 30, 2025 07:00AM
Jul 29, 2025 07:02AM
May 28, 2024 08:35AM
May 28, 2024 08:30AM
May 2, 2024 04:05PM Sight Sciences Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Financial Guidance
Apr 10, 2024 04:11PM
Apr 10, 2024 04:05PM
Apr 10, 2024 04:05PM
Oct 26, 2023 05:29PM
Oct 3, 2023 08:30AM
Jun 21, 2023 08:36AM
Jun 21, 2023 08:30AM Cigna Expands Coverage of Glaucoma Surgical Procedures to Include Canaloplasty and Goniotomy (Trabeculotomy)
May 23, 2023 08:30AM
May 8, 2023 05:28AM
May 6, 2023 11:30AM
May 1, 2023 04:05PM
May 1, 2023 04:05PM
Mar 9, 2023 08:30AM
Mar 9, 2023 08:30AM Sight Sciences Launches the Ergo-Series of the OMNI® Surgical System
Jan 26, 2023 08:30AM
Jan 26, 2023 08:30AM
Jan 4, 2023 10:00AM
Dec 8, 2022 08:30AM
Dec 8, 2022 08:30AM
Nov 3, 2022 08:30AM
Nov 3, 2022 08:30AM Sight Sciences Announces Publication of Clinical Data Demonstrating Standalone Effectiveness of the OMNI® Surgical System in Pseudophakic Glaucoma Patients with Uncontrolled Pressure Following a Prev
Sep 29, 2022 08:33AM
Sep 29, 2022 08:30AM
Sep 29, 2022 08:30AM
Sep 28, 2022 08:30AM
Sep 16, 2022 08:00AM
Sep 13, 2022 03:01AM
Sep 13, 2022 03:01AM Sight Sciences Announces Completion of Enrollment in SAHARA, a Randomized Clinical Trial of the TearCare® System vs Restasis®
Aug 23, 2022 08:08AM
Aug 23, 2022 08:03AM
Aug 23, 2022 08:03AM
Aug 16, 2022 08:07AM
Aug 16, 2022 08:01AM
Aug 16, 2022 08:01AM
May 31, 2022 08:00AM Sight Sciences’ OMNI® Surgical System Reduces IOP, Daily Fluctuations in IOP and Medication Use, as Shown in Newly Published 12-Month Clinical Data
Apr 20, 2022 04:05PM
Mar 24, 2022 04:05PM
Mar 24, 2022 04:04PM
Mar 2, 2022 08:00AM
Feb 17, 2022 08:00AM
Jan 10, 2022 05:50AM
Dec 22, 2021 08:02AM Sight Sciences (SGHT) Receives FDA 510(k) Clearance of the TearCare System for Treatment of Meibomian Gland Dysfunction, the Leading Cause of Dry Eye Disease
Dec 22, 2021 08:00AM

322,084 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All